FDA Approves At-Home Starting Dose for Lecanemab - Quiz - MDSpire

FDA Approves At-Home Starting Dose for Lecanemab

Patients may begin lecanemab-irmb treatment at home through self-administration or administration by a caregiver, according to the FDA.

  • By

  • Kathryn Wighton

  • July 13, 2026

  • 3 min

Share

Original Source(s)

FDA Approves At-Home Starting Dose for Lecanemab

  • by Kathryn Wighton

  • July 13, 2026

Related Content

Anemia Tied to Higher Dementia Risk

Older adults with anemia showed elevated Alzheimer-related biomarkers and a higher hazard of dementia over follow-up

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

Hospital Admission May Raise Health Care Spending in Dementia

Quasi-experimental analysis of nearly 900,000 emergency department visits found no evidence of lower mortality among admitted patients.